ClinicalTrials.Veeva

Menu

Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction

M

Manuel Sanchez Luna

Status

Enrolling

Conditions

Preterms
Infarction Cerebral

Treatments

Diagnostic Test: Routine cranial ultrasounds

Study type

Observational

Funder types

Other

Identifiers

NCT05918016
Neuro.Neo.1.IVH

Details and patient eligibility

About

Observational study of preterm infant with a gestational age < 30 weeks born between 2017-2023 in Neonatal Care Unit in Gregorio Marañon Hospital (Madrid, Spain). We use a new ultrasonographic prognostic scale of periventricular hemorrhagic infarction for neurodevelopmental outcome at age 2 years.

Enrollment

360 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestacional Age < 30 weeks

Exclusion criteria

  • Brain malformation
  • Genetic syndrome
  • Metabolic disorders
  • Chromosomal abnormality
  • None cranial ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Manuel Sánchez Luna, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems